PORTSMOUTH, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)KOCHHAR CANCER RESEARCH FOUNDATION, founded in 2004, is a community nonprofit in the Medical Research sector that reported $3.1M in total revenue in fiscal year 2023. The organization ran a surplus of $3.1M, a strong 99% operating margin.
To develop and test gene-based vaccines for the prevention and treatment of cancer in cancer mouse models
Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $774,226 | $6,122,150 | -0.9% |
| Expenses | $1,281,273 | $2,892,881 | -0.6% |
| Net Income | $-507,047 | $3,229,269 | -1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Ruby Kochhar MD | President | 60.00 |
Director
|
$887,524 | $0 | $887,524 |
| Jay Umbreit MD PhD | Board Member | 0.25 |
Officer
|
$0 | $0 | $0 |
| Mark Wilkowski MD | Board Member | 0.25 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $774,226 | $1,281,273 | $7,469,084 | $-507,047 |
| 2024 | No data | No data | No data | No data |
| 2023 | $3,106,694 | $27,718 | $3,493,307 | $3,078,976 |
Compare KOCHHAR CANCER RESEARCH FOUNDATION with other nonprofits in Virginia and across the country.